EA200200456A1 - METHOD OF TREATING DISEASES ASSOCIATED WITH ENDOCRINE SYSTEM DISORDERS - Google Patents
METHOD OF TREATING DISEASES ASSOCIATED WITH ENDOCRINE SYSTEM DISORDERSInfo
- Publication number
- EA200200456A1 EA200200456A1 EA200200456A EA200200456A EA200200456A1 EA 200200456 A1 EA200200456 A1 EA 200200456A1 EA 200200456 A EA200200456 A EA 200200456A EA 200200456 A EA200200456 A EA 200200456A EA 200200456 A1 EA200200456 A1 EA 200200456A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- energy
- organs
- reflexotherapy
- zones
- patients
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к медицине, а именно к области энергорефлексотерапии и может быть использовано для коррекции эндокринных нарушений. Предлагаемый способ универсален, учитывает особенности этиопатогенеза, безопасен в отношении осложнений и отдаленных негативных последствий. Воздействие на биологически активные точки и/или зоны энергорефлексотерапии осуществляют с учетом концепции У-СИН в проекции меридианов органов, относящихся к первоэлементу «Дерево», и дополнительно органов, находящихся в созидательных связях с указанным, а именно органов, относящихся к первоэлементам «Огонь» и «Вода» для пациентов Ян-энерготипа, а также органов, находящихся в деструктивных связях, относящихся к первоэлементам «Земля» и «Металл» для пациентов Инь-энерготипа. Для примера, при нарушениях деятельности гипоталамо-гипофизарно-надпочечниковой системы воздействие оказывают на биологически активные точки и/или зоны энергорефлексотерапии в проекциях меридианов перикарда и/или трех обогревателей, например MC6, TR15, AP13, AP28 соответственно.The invention relates to medicine, namely to the field of energy reflexotherapy and can be used for the correction of endocrine disorders. The proposed method is universal, takes into account the characteristics of etiopathogenesis, safe in relation to complications and long-term negative consequences. The impact on the biologically active points and / or zones of energy reflexotherapy is carried out taking into account the concept of U-SIN in the projection of the meridians of the organs belonging to the primary element "Tree", and additionally organs that are in constructive connections with the above, namely, those belonging to the primary elements "Fire" and “Water” for patients of Yang-energy type, as well as organs that are in destructive connections, related to the primary elements “Earth” and “Metal” for patients of Yin-energy type. For example, when the activity of the hypothalamic-pituitary-adrenal system is impaired, they affect biologically active points and / or zones of energy reflexotherapy in the projections of the pericardium meridians and / or three heaters, for example MC6, TR15, AP13, AP28, respectively.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA200200456A EA005224B1 (en) | 2002-01-28 | 2002-01-28 | Method for treating diseases associated with disorders in endocrine system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA200200456A EA005224B1 (en) | 2002-01-28 | 2002-01-28 | Method for treating diseases associated with disorders in endocrine system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200200456A1 true EA200200456A1 (en) | 2003-08-28 |
| EA005224B1 EA005224B1 (en) | 2004-12-30 |
Family
ID=34585799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200200456A EA005224B1 (en) | 2002-01-28 | 2002-01-28 | Method for treating diseases associated with disorders in endocrine system |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA005224B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA015397B1 (en) * | 2007-09-26 | 2011-08-30 | Виктор Геннадьевич Соломатов | Method for the treatment of thyroid gland endocrine disorders |
-
2002
- 2002-01-28 EA EA200200456A patent/EA005224B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA005224B1 (en) | 2004-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE347366T1 (en) | USE OF ACTIVE VITAMIN D ANALOGUE FOR THE TREATMENT OF PROSTATE DISEASES | |
| ATE319474T1 (en) | TREATMENT OF AUTOIMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTOANTIGENS | |
| DK1363608T3 (en) | Formulations comprising ibuprofen and diphenhydramine and their use in the treatment of sleep disorders | |
| DK0822829T3 (en) | Use of glial neurotrophic factor (GDNF) for the treatment of hearing disorders | |
| DE60107065D1 (en) | TREATMENT OF CONGESTIVE HEART FAILURE BY PRE-TREATED AUTOLOGOUS BLOOD | |
| NO20055187L (en) | Procedures for the treatment and prevention of lower urinary tract symptoms | |
| FR2819723B1 (en) | HALOGEN COMPOSITION, PREPARATION METHOD AND USES THEREOF | |
| ATE368455T1 (en) | USE OF (+)-TRAMADOL, O-DEMETHYLTRAMADOL, O-DESMETHYL-N-MONO-DESMETHYL-TRAMADOL FOR THE THERAPY OF URINARY INCONTINENCE | |
| TW200501934A (en) | Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set | |
| ATE359798T1 (en) | USE OF DEXTRANSULPHATE TO TREAT IBMIR | |
| AR032440A1 (en) | METHOD TO REDUCE OR ELIMINATE TOBACCO | |
| BRPI0409699A (en) | methods of inducing the diuretic effect, inducing, maintaining or restoring the diuretic effect of a non-adenosine modifying diuretic, maintaining, restoring or improving renal function in a patient, inducing diuresis, preventing the onset of renal impairment in a patient with fluid or CHF overload, treating CHF patients and improving overall health outcomes, pharmaceutical composition and uses | |
| EA200200456A1 (en) | METHOD OF TREATING DISEASES ASSOCIATED WITH ENDOCRINE SYSTEM DISORDERS | |
| DK1150698T3 (en) | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction | |
| ATE297702T1 (en) | INDUCTION OF IMMUNOLOGICAL TOLERANCE | |
| DK1244438T3 (en) | Use of beta-adrenoceptor antagonists in the manufacture of a medicament for the treatment of diseases of the outer retina | |
| NO20024381L (en) | Preparation for use in the treatment of ocular hypertension and glaucoma | |
| EA200200033A1 (en) | METHOD OF TREATING VIRAL HEPATITIS | |
| DK1137420T3 (en) | Use of a combination of a purine and a nitrogen monoxide donor for the prevention or treatment of sexual dysfunction | |
| Korobov | A. KOROBOV-V. KOROBOV PHOTOTHERAPEUTIC DEVICES OF “BARVA” SERIES | |
| Husain | Homeopathy in Practice: Clinical Insights into Homeopathy & Remedies | |
| Bickford | Biological effects of full-spectrum lighting | |
| JP2022172050A (en) | Healthy morning-erection assist device | |
| MXPA02001219A (en) | Liquid pharmaceutical composition for treating bone diseases. | |
| Thorne | Discussion on the Treatment by Physical Methods of Medical Disabilities Induced by the War |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM BY KZ KG MD TJ TM |
|
| QB4A | Registration of a licence in a contracting state | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |